Outcome measures pre-ustekinumab and at last follow-up (median follow-up of 13.5 months (range 7–26) after initiation of ustekinumab)
| Outcome | Pre-ustekinumab | Last follow-up | p Value |
|---|---|---|---|
| Prednisolone dose, mg, median (IQR) | 20 (15, 25) | 5 (2.9, 8.1) | 0.001 |
| ESR, mm/h, median (IQR) | 14 (5.8, 29.3) | 15 (9.8, 28.5) | 0.572 |
| CRP, mg/L, median (IQR) | 12.2 (3.4, 21) | 4.8 (2.8, 15) | 0.177 |
| Stopped glucocorticoids, n (%) | – | 4 (29) | – |
| Stopped other immunosuppressants, n (%) | – | 11 (92) | – |
CRP, C reactive protein, normal range 0–5 mg/L; ESR, erythrocyte sedimentation rate, normal range 0–30 mm/h.